Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart.
A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
North America is the largest consumption place, with a consumption market share nearly 61% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 39%.
According to this study, over the next five years the Total Artificial Heart market will register a 19.7% CAGR in terms of revenue, the global market size will reach US$ 59 million by 2024, from US$ 24 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Total Artificial Heart business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Total Artificial Heart market by product type, application, key manufacturers and key regions and countries.
This study considers the Total Artificial Heart value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
SynCardia
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
SynCardia
BiVACOR
CARMAT
ReinHeart TAH GmbH
Cleveland Heart
AbioMed
OregonHeart, Inc
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Total Artificial Heart consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Total Artificial Heart market by identifying its various subsegments.
Focuses on the key global Total Artificial Heart manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Total Artificial Heart with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Total Artificial Heart submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
